Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Holdings
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Quarterly results
CC transcript

ARYx Therapeutics, Inc. (ARYX) Create: Alert

All | News | Filings
Date FiledTypeDescription
04/11/2011 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
04/08/2011 15-12B Form 15-12B - Securities registration termination [Section 12(b)]
03/31/2011 NT 10-K Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405
03/29/2011 25 Form 25 - Notification of the removal from listing and registration of matured, redeemed or retired securities
03/22/2011 8-K Quarterly results
03/21/2011 SC 13D/A Growth Equity Opportunities Fund, LLC has filed a Schedule 13D for ARYx Therapeutics, Inc.
03/14/2011 4 Growth Equity Opportunities Fund, LLC (10% Owner) has filed a Form 4 on ARYx Therapeutics, Inc.
03/14/2011 4 Form 4 - Statement of changes in beneficial ownership of securities
03/14/2011 4 BASKETT FOREST (10% Owner) has filed a Form 4 on ARYx Therapeutics, Inc.
Txns: Sold 4,469,274 shares @ $0.073, valued at $326.3k
03/14/2011 4 KOLLURI KRISHNA KITTU (10% Owner) has filed a Form 4 on ARYx Therapeutics, Inc.
Txns: Sold 4,469,274 shares @ $0.073, valued at $326.3k
03/14/2011 4 KERINS PATRICK J (10% Owner) has filed a Form 4 on ARYx Therapeutics, Inc.
Txns: Sold 4,469,274 shares @ $0.073, valued at $326.3k
03/11/2011 8-K Form 8-K - Current report
03/09/2011 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "ARYX THERAPEUTICS INFORMED OF ADDITIONAL DELAY BY FDA AND BEGINS WIND-DOWN OF OPERATIONS"
02/17/2011 8-K Other Events
02/11/2011 SC 13G/A NOMURA INTERNATIONAL PLC reports a 0% stake in ARYx THERAPEUTICS, INC.
02/10/2011 SC 13G/A ARYx Therapeutics, Inc. reports a 4.6% stake in ARYx Therapeutics Inc
02/07/2011 8-K Form 8-K - Current report
01/31/2011 SC 13G/A Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend]
12/21/2010 8-K Form 8-K - Current report
12/16/2010 8-K Cost Associated with Exit or Disposal Activities, Departure of Directors or Certain Officers; Election of Directors; Appointm...
Docs: "ARYX THERAPEUTICS PROVIDES UPDATE ON COMPANY STATUS"
11/26/2010 8-K Form 8-K - Current report
11/15/2010 8-K Quarterly results
Docs: "ARYX THERAPEUTICS REPORTS THIRD QUARTER RESULTS"
11/15/2010 10-Q Quarterly Report for the period ended September 30, 2010
10/22/2010 EFFECT Form EFFECT -
10/12/2010 S-3 Form S-3 - Registration statement under Securities Act of 1933
10/12/2010 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans
10/08/2010 8-K Form 8-K - Current report
10/07/2010 SC 13D/A MPM BIOVENTURES III L.P. has filed a Schedule 13D for ARYx THERAPEUTICS, INC.
10/04/2010 4 SIMON NICHOLAS J III (10% Owner) has filed a Form 4 on ARYx Therapeutics, Inc.
10/04/2010 4 MPM BIOVENTURES III-QP L.P. (10% Owner) has filed a Form 4 on ARYx Therapeutics, Inc.
10/04/2010 4 EVNIN LUKE (10% Owner) has filed a Form 4 on ARYx Therapeutics, Inc.
Txns: Bought 500,000 warrants @ $0.5, valued at $250k
08/27/2010 D Form D - Notice of Exempt Offering of Securities
08/19/2010 SC 13D/A MPM BIOVENTURES III L.P. has filed a Schedule 13D for ARYx THERAPEUTICS, INC.
08/17/2010 4 EVNIN LUKE (10% Owner) has filed a Form 4 on ARYx Therapeutics, Inc.
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy